Literature DB >> 23759591

Inter-telomeric recombination is present in telomerase-positive human cells.

Margit Dlaska1, Patrick Schöffski, Oliver E Bechter.   

Abstract

Immortal cells require a mechanism of telomere length control in order to divide infinitely. One mechanism is telomerase, an enzyme that compensates the loss of telomeric DNA. The second mechanism is the alternative lengthening of telomeres (ALT) pathway. In ALT pathway cells, homologous recombination between telomeric DNA is the mechanism by which telomere homeostasis is achieved. We developed a novel homologous recombination reporter system that is able to measure inter-telomeric recombination in a sensitive manner. We asked the fundamental question if homologous recombination between different telomeres is present in telomerase-positive cells. In this in vitro study, we showed that homologous recombination between telomeres is detectable in ALT cells with the same frequency as in cells that utilize the telomerase pathway. We further described an ALT cell clone that showed peaks of recombination which were not detected in telomerase-positive clones. In telomerase-positive cells the frequency of inter-telomeric recombination was not increased by shortened telomeres or by a fragile telomere phenotype induced with aphidicolin. ALT cells, in contrast, responded to aphidicolin with an increase in the frequency of recombination. Our results indicate that inter-telomeric recombination is present in both pathways of telomere length control, but the factors that increase recombination are different in ALT and telomerase-positive cells.

Entities:  

Keywords:  ALT; homologous recombination; immortal; recombination reporter; telomerase; telomeres

Mesh:

Substances:

Year:  2013        PMID: 23759591      PMCID: PMC3737311          DOI: 10.4161/cc.25136

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  59 in total

Review 1.  Mechanisms of common fragile site instability.

Authors:  Thomas W Glover; Martin F Arlt; Anne M Casper; Sandra G Durkin
Journal:  Hum Mol Genet       Date:  2005-10-15       Impact factor: 6.150

2.  Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol.

Authors:  Brittney-Shea Herbert; Amelia E Hochreiter; Woodring E Wright; Jerry W Shay
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 3.  How telomeres are replicated.

Authors:  Eric Gilson; Vincent Géli
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

Review 4.  Replication fork stalling at natural impediments.

Authors:  Ekaterina V Mirkin; Sergei M Mirkin
Journal:  Microbiol Mol Biol Rev       Date:  2007-03       Impact factor: 11.056

5.  Normal human chromosomes have long G-rich telomeric overhangs at one end.

Authors:  W E Wright; V M Tesmer; K E Huffman; S D Levene; J W Shay
Journal:  Genes Dev       Date:  1997-11-01       Impact factor: 11.361

6.  Telomeres, telomerase, and aging: origin of the theory.

Authors:  A M Olovnikov
Journal:  Exp Gerontol       Date:  1996 Jul-Aug       Impact factor: 4.032

7.  Normal human telomeres are not late replicating.

Authors:  W E Wright; V M Tesmer; M L Liao; J W Shay
Journal:  Exp Cell Res       Date:  1999-09-15       Impact factor: 3.905

8.  Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body.

Authors:  T R Yeager; A A Neumann; A Englezou; L I Huschtscha; J R Noble; R R Reddel
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

Review 9.  Shelterin: the protein complex that shapes and safeguards human telomeres.

Authors:  Titia de Lange
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 12.890

10.  Elevated rates of sister chromatid exchange at chromosome ends.

Authors:  M Katharine Rudd; Cynthia Friedman; Sean S Parghi; Elena V Linardopoulou; Li Hsu; Barbara J Trask
Journal:  PLoS Genet       Date:  2007-02-23       Impact factor: 5.917

View more
  2 in total

Review 1.  Telomerase lost?

Authors:  James M Mason; Thomas A Randall; Radmila Capkova Frydrychova
Journal:  Chromosoma       Date:  2015-07-11       Impact factor: 4.316

2.  Keeping those telomeres short! an innovative intratumoral long-term drug delivery system.

Authors:  B H Laster; C Isaacson; E Perets; M Msamra; E Priel; J Kalef-Ezra; J Kost
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-30       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.